Who owns the CALCIUM CORBIERE trademark?

The CALCIUM CORBIERE trademark is owned by Opella Healthcare Group SAS.

What class is the CALCIUM CORBIERE trademark registered in?

The CALCIUM CORBIERE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for CALCIUM CORBIERE?

The USPTO serial number for CALCIUM CORBIERE is 79428775.

What is the registration number for CALCIUM CORBIERE?

CALCIUM CORBIERE is registered under USPTO registration number 8190986.

CAL

USPTO Trademark Record

REGISTERED

CALCIUM CORBIERE

SN 79428775·Reg 8190986·Filed Jun 16, 2025

Owner Opella Healthcare Group SAS

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

CALCIUM CORBIERE (Serial No. 79428775), Registration No. 8190986, is a registered US trademark filed on Jun 16, 2025 by Opella Healthcare Group SAS. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: March 31, 2032

Mark Intelligence

CALCIUM CORBIERE (Reg. #8190986) is a registered US trademark that has been protecting its owner, Opella Healthcare Group SAS, since 2025. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 16, 2025

SERIAL

79428775

REG#

8190986

REGISTERED

Mar 31, 2026

Owner

Applicant

Opella Healthcare Group SAS

Entity

S.A.S / S.A.R.L (French)

Address

157 avenue Charles de Gaulle, F-92200 Neuilly-Sur-Seine

Country

Attorney

NameJonathan M. Rixen

Law firm

Jonathan M. Rixen Dennemeyer & Associates, LLC

Docket

USMM10169700

Address

230 W. Monroe St., Suite 2100, Chicago, IL 60606, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJun 16, 2025

Serial Number79428775

Registration No.8190986

Registration DateMar 31, 2026

Status DateMar 31, 2026

Published for OppositionFeb 10, 2026

Mark TypeStandard characters

Attorney DocketUSMM10169700

Status DescriptionLive and registered

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

36 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Sep 24, 2026

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Sep 08, 2026

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Sep 08, 2026

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 30, 2026

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Mar 31, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 31, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Feb 10, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 10, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

REFUSAL PROCESSED BY IB

Feb 05, 2026

REFUSAL PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 04, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

REFUSAL PROCESSED BY IB

Jan 29, 2026

REFUSAL PROCESSED BY IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 15, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 14, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 13, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 13, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Jan 09, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jan 09, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 09, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 07, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Jan 07, 2026

PREVIOUS ALLOWANCE COUNT WITHDRAWN

NON-FINAL ACTION WRITTEN

Jan 07, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jan 07, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 07, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

REFUSAL PROCESSED BY IB

Jan 01, 2026

REFUSAL PROCESSED BY IB

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 19, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 19, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 19, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY MPU

Dec 12, 2025

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Dec 12, 2025

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Nov 05, 2025

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

ASSIGNED TO EXAMINER

Nov 04, 2025

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Nov 04, 2025

NON-FINAL ACTION WRITTEN

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Aug 05, 2025

LIMITATION FROM ORIGINAL APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 05, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Aug 05, 2025

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Jul 24, 2025

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

CALCIUM CORBIERE

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Opella Healthcare Group SAS

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Jonathan M. Rixen

Resources

Company